26.81
price down icon0.70%   -0.19
pre-market  Vorhandelsmarkt:  27.23   0.42   +1.57%
loading
Schlusskurs vom Vortag:
$27.00
Offen:
$27.04
24-Stunden-Volumen:
1.20M
Relative Volume:
1.33
Marktkapitalisierung:
$1.58B
Einnahmen:
$13.05M
Nettoeinkommen (Verlust:
$-60.54M
KGV:
-23.11
EPS:
-1.16
Netto-Cashflow:
$-37.82M
1W Leistung:
-13.04%
1M Leistung:
-18.49%
6M Leistung:
-39.75%
1J Leistung:
-28.87%
1-Tages-Spanne:
Value
$26.39
$27.82
1-Wochen-Bereich:
Value
$26.39
$31.02
52-Wochen-Spanne:
Value
$26.39
$71.71

Janux Therapeutics Inc Stock (JANX) Company Profile

Name
Firmenname
Janux Therapeutics Inc
Name
Telefon
(858) 751-4493
Name
Adresse
10955 VISTA SORRENTO PARKWAY, SAN DIEGO
Name
Mitarbeiter
81
Name
Twitter
Name
Nächster Verdiensttermin
2024-08-06
Name
Neueste SEC-Einreichungen
Name
JANX's Discussions on Twitter

Vergleichen Sie JANX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
JANX
Janux Therapeutics Inc
26.81 1.58B 13.05M -60.54M -37.82M -1.16
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.74 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
617.00 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
567.09 34.59B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.76 33.10B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
271.04 29.15B 3.81B -644.79M -669.77M -6.24

Janux Therapeutics Inc Stock (JANX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-03 Bestätigt BTIG Research Buy
2024-12-03 Bestätigt H.C. Wainwright Buy
2024-11-22 Eingeleitet Leerink Partners Outperform
2024-10-24 Eingeleitet UBS Buy
2024-09-06 Eingeleitet Stifel Buy
2024-05-30 Eingeleitet Scotiabank Sector Perform
2024-03-21 Eingeleitet BTIG Research Buy
2024-03-20 Eingeleitet Cantor Fitzgerald Overweight
2023-04-06 Eingeleitet Wedbush Outperform
2022-11-14 Eingeleitet William Blair Outperform
Alle ansehen

Janux Therapeutics Inc Aktie (JANX) Neueste Nachrichten

pulisher
Apr 01, 2025

(JANX) Investment Report - news.stocktradersdaily.com

Apr 01, 2025
pulisher
Mar 28, 2025

Janux Therapeutics stock hits 52-week low at $28.92 By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Janux Therapeutics stock hits 52-week low at $28.92 - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

Is Janux Therapeutics Inc. (NASDAQ:JANX) the Best Up and Coming Stock to Buy According to Wall Street Analysts? - Yahoo Finance

Mar 28, 2025
pulisher
Mar 26, 2025

Is Janux Therapeutics, Inc. (NASDAQ:JANX) the Best Small Cap Stock to Buy Before They Explode? - Insider Monkey

Mar 26, 2025
pulisher
Mar 25, 2025

Janux Therapeutics, Inc. (JANX): Among Stocks Receiving the Most Insider Love in March - MSN

Mar 25, 2025
pulisher
Mar 25, 2025

We're Interested To See How Janux Therapeutics (NASDAQ:JANX) Uses Its Cash Hoard To Grow - Yahoo Finance

Mar 25, 2025
pulisher
Mar 24, 2025

12 Best Up and Coming Stocks to Buy According to Wall Street Analysts - Insider Monkey

Mar 24, 2025
pulisher
Mar 24, 2025

First Week of JANX November 21st Options Trading - Nasdaq

Mar 24, 2025
pulisher
Mar 21, 2025

RA Capital Management, L.P. Increases Stake in Janux Therapeutics Inc - GuruFocus.com

Mar 21, 2025
pulisher
Mar 21, 2025

Insiders Are Spending Big: 15 Stocks Leading in March - Insider Monkey

Mar 21, 2025
pulisher
Mar 20, 2025

Is Janux Therapeutics (JANX) a Worst High-Risk High-Reward Growth Stock to Buy? - Insider Monkey

Mar 20, 2025
pulisher
Mar 19, 2025

10 Worst High-Risk High-Reward Growth Stocks To Buy - Insider Monkey

Mar 19, 2025
pulisher
Mar 17, 2025

Commit To Buy Janux Therapeutics At $25, Earn 30% Annualized Using Options - Nasdaq

Mar 17, 2025
pulisher
Mar 14, 2025

Biotech Alert: Searches spiking for these stocks today - Yahoo Finance

Mar 14, 2025
pulisher
Mar 12, 2025

EGFR Non-Small Cell Lung Cancer Clinical and Non-Clinical - openPR

Mar 12, 2025
pulisher
Mar 12, 2025

Janux Therapeutics (NASDAQ:JANX) Shares Gap Up Following Insider Buying Activity - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Insiders Are Loading Up on These 4 Biotech Stocks Now - 24/7 Wall St.

Mar 11, 2025
pulisher
Mar 11, 2025

(JANX) Proactive Strategies - news.stocktradersdaily.com

Mar 11, 2025
pulisher
Mar 10, 2025

JANX stock touches 52-week low at $29.62 amid market shifts By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 10, 2025

JANX stock touches 52-week low at $29.62 amid market shifts - Investing.com India

Mar 10, 2025
pulisher
Mar 10, 2025

Sunday Insider Moves: Top Buys and Sells from Friday’s Disclosures By Investing.com - Investing.com Australia

Mar 10, 2025
pulisher
Mar 10, 2025

Sunday Insider Moves: Top Buys and Sells from Friday’s Disclosures - Investing.com India

Mar 10, 2025
pulisher
Mar 09, 2025

Ra Capital Management, L.P. Purchases 341,742 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) Stock - Defense World

Mar 09, 2025
pulisher
Mar 09, 2025

Ra Capital Management, L.P. Purchases 110,206 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) Stock - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Major Investment Alert: Janux Therapeutics Stock Sees Massive Buy-In! - TipRanks

Mar 08, 2025
pulisher
Mar 08, 2025

Proficio Capital Partners LLC Invests $1.35 Million in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

Ra capital management buys $25.3 million in Janux therapeutics stock By Investing.com - Investing.com Australia

Mar 08, 2025
pulisher
Mar 07, 2025

Ra capital management buys $25.3 million in Janux therapeutics stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

HC Wainwright Has Pessimistic Outlook of JANX Q1 Earnings - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

Janux Therapeutics (JANX) Projected to Post Quarterly Earnings on Friday - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Janux Therapeutics chief business officer sells shares for $107,174 By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Given Consensus Rating of “Buy” by Brokerages - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Janux Therapeutics chief business officer sells shares for $107,174 - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Janux Therapeutics, Inc. (JANX): Among The Stocks With At Least $30 Million In Insider Spending Recently - Insider Monkey

Mar 05, 2025
pulisher
Mar 05, 2025

JANUX THERAPEUTICS Earnings Preview: Recent $JANX Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 05, 2025
pulisher
Mar 05, 2025

10 Stocks With At Least $30 Million In Insider Spending Recently - Insider Monkey

Mar 05, 2025
pulisher
Mar 04, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Acquired by Rhumbline Advisers - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Stock Holdings Lifted by New York State Common Retirement Fund - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Janux Therapeutics (NASDAQ:JANX) Given “Buy” Rating at HC Wainwright - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Janux Therapeutics (NASDAQ:JANX) Sets New 52-Week Low on Analyst Downgrade - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

Promising Developments and Strong Financial Position Support Buy Rating for Janux Therapeutics - TipRanks

Mar 03, 2025
pulisher
Mar 03, 2025

Janux Therapeutics’ (JANX) Outperform Rating Reiterated at Wedbush - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

Positive Outlook for Janux Therapeutics Inc. Driven by Unique Therapeutic Potential and Strategic Advantages - TipRanks

Mar 02, 2025
pulisher
Mar 01, 2025

Janux Therapeutics price target lowered to $41 from $62 at Scotiabank - Yahoo Finance

Mar 01, 2025
pulisher
Feb 28, 2025

Janux Therapeutics Reports Strong Financial Position and Clinical Progress - TipRanks

Feb 28, 2025

Finanzdaten der Janux Therapeutics Inc-Aktie (JANX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
Kapitalisierung:     |  Volumen (24h):